Alternatives to Cequa If You Can't Fill Your Prescription

When Cequa Isn't an Option, You Still Have Choices

If you've been prescribed Cequa (Cyclosporine ophthalmic solution 0.09%) for dry eye disease but can't fill your prescription — whether because of cost, insurance denial, or availability — you're not out of options. Several other FDA-approved medications treat dry eye disease effectively, and your doctor can help you find one that works for your situation.

In this guide, we'll explain what Cequa does, how it works, and walk through the most common alternatives available in 2026.

What Is Cequa and How Does It Work?

Cequa is a prescription eye drop approved by the FDA in 2018 to increase tear production in adults with dry eye disease. It's made by Sun Pharmaceutical Industries and contains cyclosporine at a 0.09% concentration — delivered using a proprietary NCELL nanomicellar technology designed to improve how well the drug reaches the surface of your eye.

Cyclosporine is a calcineurin inhibitor. In simple terms, it blocks a protein that triggers inflammation on the surface of your eyes. When that inflammation is reduced, your tear glands can function better and produce more natural tears.

You use Cequa by placing one drop in each eye twice a day, using a fresh single-use vial each time. For a deeper dive into the science, see our article on how Cequa works.

Why Patients Look for Alternatives

Cequa is a good medication, but several factors push patients toward alternatives:

• Cost: Without insurance, Cequa costs roughly $624 to $917 per month
• Insurance coverage: Many plans don't cover Cequa or require step therapy and prior authorization
• Availability: Some pharmacies don't stock it (read more about why Cequa is hard to find)
• Side effects: Some patients don't tolerate the eye pain or stinging that can occur with Cequa

Alternatives to Cequa for Dry Eye Disease

Here are the most common alternatives your eye doctor may consider. Each one works a bit differently, so the best choice depends on your specific situation, insurance coverage, and how your eyes respond.

1. Restasis (Cyclosporine 0.05%)

What it is: Restasis was the first cyclosporine eye drop approved for dry eye, hitting the market in 2003. It contains a lower concentration of cyclosporine (0.05%) compared to Cequa's 0.09%.

How it works: Same mechanism as Cequa — it's a calcineurin inhibitor that reduces ocular inflammation to help your eyes produce more tears.

Key differences from Cequa:

• Lower cyclosporine concentration (0.05% vs. 0.09%)
• Generic available — generic cyclosporine 0.05% costs approximately $90 per month compared to $400+ for brand-name Restasis
• Better insurance coverage since generics are available
• May take longer to see full effect (3-6 months)

Cost: Brand Restasis ~$400/month; generic cyclosporine 0.05% ~$90/month

Best for: Patients who need an affordable cyclosporine option or whose insurance requires trying generic cyclosporine first.

2. Xiidra (Lifitegrast 5%)

What it is: Xiidra is a prescription eye drop that takes a completely different approach to treating dry eye. Rather than using cyclosporine, it contains lifitegrast — an LFA-1 antagonist.

How it works: Xiidra blocks a specific protein (LFA-1) on the surface of immune cells that drives inflammation in dry eye. By preventing these immune cells from binding to the eye's surface, Xiidra reduces inflammation and can improve both signs and symptoms of dry eye.

Key differences from Cequa:

• Different drug class — not a cyclosporine product
• May work faster for some patients (improvements seen in as little as 2 weeks for symptoms)
• Common side effect: dysgeusia (an unusual taste in the mouth after use)
• No generic available

Cost: ~$1,000/month without insurance

Best for: Patients who haven't responded to cyclosporine products or want a non-cyclosporine option.

3. Vevye (Cyclosporine 0.1%)

What it is: Vevye is the newest cyclosporine eye drop, approved by the FDA in 2023. It contains a slightly higher concentration of cyclosporine (0.1%) in a unique water-free, preservative-free formulation.

How it works: Same calcineurin-inhibiting mechanism as Cequa and Restasis, but the water-free vehicle may improve comfort and drug delivery.

Key differences from Cequa:

• Higher cyclosporine concentration (0.1% vs. 0.09%)
• Water-free formulation — may be more comfortable for some patients
• Comes in a multi-dose bottle (not single-use vials)
• Clinical trials showed improvement as early as 4 weeks
• Approved for both signs and symptoms of dry eye

Cost: ~$1,070/month without insurance

Best for: Patients looking for a newer cyclosporine formulation, especially those who prefer a multi-dose bottle over single-use vials.

4. Tyrvaya (Varenicline Nasal Spray 0.03 mg)

What it is: Tyrvaya is a completely different kind of dry eye treatment — it's a nasal spray, not an eye drop. Approved by the FDA in 2021, it takes a novel approach to stimulating tear production.

How it works: Tyrvaya activates the trigeminal nerve through the nasal passages, which signals the lacrimal glands to produce more tears. It targets the root cause of tear deficiency without putting anything directly in your eyes.

Key differences from Cequa:

• Nasal spray — no eye drops at all
• Works through a completely different pathway (nerve stimulation vs. anti-inflammation)
• May be good for patients who can't tolerate eye drops
• Common side effects: sneezing, cough, throat irritation

Cost: ~$930/month without insurance

Best for: Patients who can't tolerate eye drops or haven't responded to anti-inflammatory approaches.

Over-the-Counter Options

While not direct replacements for Cequa, over-the-counter artificial tears can help manage mild dry eye symptoms while you work on getting a prescription medication. Popular options include:

• Systane Complete (~$22/month)
• Refresh Optive
• TheraTears
• Preservative-free artificial tears (single-use vials) — best if you use drops more than 4 times daily

Artificial tears provide temporary relief by supplementing your natural tear film, but they don't address the underlying inflammation that causes dry eye disease. Your doctor will likely recommend them as a complement to — not a replacement for — prescription treatment.

How to Choose the Right Alternative

Choosing the right alternative to Cequa depends on several factors:

• Insurance coverage: Generic Cyclosporine 0.05% is the most widely covered option
• Budget: If cost is the primary concern, generic Cyclosporine 0.05% at ~$90/month is the most affordable prescription option
• Tolerance: If eye drops cause too much discomfort, Tyrvaya (nasal spray) avoids the issue entirely
• Response to treatment: If cyclosporine hasn't worked for you, Xiidra offers a completely different mechanism

Talk to your ophthalmologist or optometrist about which option makes the most sense for your eyes, your insurance, and your preferences.

Final Thoughts

Not being able to fill your Cequa prescription is frustrating, but dry eye disease has more treatment options in 2026 than ever before. Whether it's a more affordable generic cyclosporine, a different drug class like Xiidra, a newer formulation like Vevye, or an entirely different approach like Tyrvaya, there's likely an alternative that can help.

If availability is the issue rather than cost, check out our guide on how to find Cequa in stock near you — you may be able to locate it with the right tools. And for savings options on brand-name Cequa, visit our guide to saving money on Cequa.